Indoneva Pharmaceutical Private Limited
About Indoneva Pharmaceutical Private Limited
Data last updated:
Indoneva Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 July 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2023PTC416731.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Sharma and Manoj Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 38 Second Floor, Sant Nagar, New Delhi, Delhi, India – 110065.
Company details
Contact details
Indoneva Pharmaceutical Private Limited's registered office is in New Delhi, Delhi.
- Registered Address38 Second Floor, Sant Nagar, New Delhi, Delhi, India – 110065
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Indoneva Pharmaceutical Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Indoneva Pharmaceutical Private Limited, buy the company report.
Board of directors of Indoneva Pharmaceutical Private Limited
Indoneva Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Sharma | Director | 07 Jul 2023 | 3 Years 3 Months | Current |
| Manoj Kumar Singh | Director | 07 Jul 2023 | 3 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Indoneva Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indoneva Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Indoneva Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Indoneva Pharmaceutical Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Dinesh Kumar was appointed as Non- Individual Subscriber on 07 Jul 2023.
Frequently asked questions
Indoneva Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 July 2023 (3+ years old) and is registered under CIN U21001DL2023PTC416731.
Indoneva Pharmaceutical has 2 current directors:
- Rajeev Sharma - Director
- Manoj Kumar Singh - Director
The latest financial statements of Indoneva Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Indoneva Pharmaceutical is U21001DL2023PTC416731. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indoneva Pharmaceutical was incorporated on 07 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Dinesh Kumar was appointed as Non- Individual Subscriber on 07 Jul 2023. Manoj Kumar Singh was appointed as Director on 07 Jul 2023. Rajeev Sharma was appointed as Director on 07 Jul 2023.
The registered office of Indoneva Pharmaceutical is at 38 Second Floor, Sant Nagar, New Delhi, Delhi, India – 110065.
Indoneva Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Indoneva Pharmaceutical can be reached at its registered office: 38 Second Floor, Sant Nagar, New Delhi, Delhi, India – 110065.
Indoneva Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.